Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06098482 · ClinicalTrials.gov registry record · NA

An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App

A NA study of Hearing Loss, sponsored by Cochlear.

Recruiting
Registry status
NA
Development phase
46
Enrollment target
4
Study locations

NCT06098482 is a NA study of Hearing Loss that is actively recruiting participants, run by Cochlear. The registered enrollment target is 46 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06098482, a NA study of Hearing Loss, is actively recruiting participants, sponsored by Cochlear.

RECRUITING
Registry status
NA
Development phase
46 participants
Enrollment target
4
Study locations

Study Summary

The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.

Conditions Studied

Interventions

  • DEVICE Mobile Research App (MRA)
  • OTHER SOC/validated delivery of the speech perception test material

Study Locations (4)

Antwerp

  • European Institute for Otorhinolaryngology (EIORL) ENT department Sint-Augustinus Antwerp - Antwerp
  • Hoorzorg van Looveren - Wommelgem

Colorado

  • Denver Research and Technology Labs - Lone Tree

Victoria

  • HEARnet Clinical Studies - Melbourne

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2024-02-05
Est. Completion 2027-05-02
Phase NA

Sponsor

Cochlear

34 total trials

What the Registry Record Tells You About NCT06098482

The ClinicalTrials.gov registry entry for NCT06098482 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Mobile Research App (MRA) is the first listed.

NCT06098482 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Antwerp, Colorado, Victoria.

Frequently Asked Questions

What is clinical trial NCT06098482 about?

NCT06098482 is a clinical study titled "An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App". The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.

What is the current status of trial NCT06098482?

This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2024-02-05. Estimated completion is 2027-05-02.

What conditions does trial NCT06098482 study?

This clinical trial studies the following conditions: Hearing Loss.

What interventions are being tested in trial NCT06098482?

The interventions under investigation include: Mobile Research App (MRA) (DEVICE), SOC/validated delivery of the speech perception test material (OTHER).

Who is sponsoring clinical trial NCT06098482?

This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06098482 being conducted?

This trial has 4 study locations across Colorado, Victoria, Antwerp. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.